G9073
HCPCSOnc dx brst stg3-hr, no pro
Official HCPCS Level II long descriptor
Oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; stage iiia-iiib; and not t3, n1, m0; and er and/or pr positive; with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)
HCPCS Level II code G9073 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Onc dx brst stg3-hr, no pro
Added to HCPCS: 2006-01-01
Nearby codes in G9
- G9065Onc dx nsclc stg3a no progre
- G9066Onc dx nsclc stg3b-4 metasta
- G9067Onc dx nsclc dx unknown nos
- G9068Onc dx sclc/nsclc limited
- G9069Onc dx sclc/nsclc ext at dx
- G9070Onc dx sclc/nsclc ext unknwn
- G9071Onc dx brst stg1-2b hr,nopro
- G9072Onc dx brst stg1-2 noprogres
- G9074Onc dx brst stg3-noprogress
- G9075Onc dx brst metastic/ recur
- G9077Onc dx prostate t1no progres
- G9078Onc dx prostate t2no progres
- G9079Onc dx prostate t3b-t4noprog
- G9080Onc dx prostate w/rise psa
- G9083Onc dx prostate unknwn nos
- G9084Onc dx colon t1-3,n1-2,no pr
Where this code sits
Krasyn Codes for Chrome
Review coding suggestions beside a validated web workflow. Private pilot.
Request pilot accessSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.